0001658551-15-000002.txt : 20151120 0001658551-15-000002.hdr.sgml : 20151120 20151120153017 ACCESSION NUMBER: 0001658551-15-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 EFFECTIVENESS DATE: 20151120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-251392 FILM NUMBER: 151246483 BUSINESS ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-571-8872 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0707 D/A LIVE 0001658551 Amylyx Pharmaceuticals, Inc. 210 BROADWAY #201 CAMBRIDGE MA MASSACHUSETTS 02139 617-571-8872 DELAWARE None None Corporation true 2014 Joshua Cohen 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Justin Klee 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Peter B. Finn c/o Rubin and Rudman LLP 50 Rowes Wharf Boston MA MASSACHUSETTS 02110 Executive Officer Secretary Stephen D. Chubb 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director George M. Milne, PH.D. 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06c true 0001658551-15-000001 2014-03-05 true true false 10000 1630000 1440000 190000 false 28 0 0 75000 Executive Salaries false Amylyx Pharmaceuticals, Inc. Peter B. Finn Peter B. Finn Secretary 2015-11-20